Straumann Holding AG (OTCMKTS:SAUHY – Get Free Report) has earned an average recommendation of “Hold” from the six brokerages that are presently covering the company, Marketbeat.com reports. Two investment analysts have rated the stock with a sell rating, two have given a hold rating, one has given a buy rating and one has given a strong buy rating to the company.
A number of analysts have issued reports on SAUHY shares. Morgan Stanley reissued an “underweight” rating on shares of Straumann in a research report on Monday, December 15th. Citigroup restated a “sell” rating on shares of Straumann in a research report on Wednesday, January 14th.
View Our Latest Stock Analysis on Straumann
Straumann Price Performance
Straumann Company Profile
Straumann (OTCMKTS:SAUHY) is a Swiss-based dental technology company that develops, manufactures and markets restorative, regenerative and digital solutions for dental professionals. The company’s core offerings center on implant-supported restorations and components, biomaterials used for bone and soft-tissue regeneration, and a range of prosthetic products used by dentists and dental laboratories to restore oral function and aesthetics.
In addition to implant and biomaterial product lines, Straumann provides digital dentistry solutions that support treatment planning and workflows.
Read More
Receive News & Ratings for Straumann Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Straumann and related companies with MarketBeat.com's FREE daily email newsletter.
